Bio-Techne Makes Big Push Into Liquid Biopsy With Exosome Acquisition
Executive Summary
Bio-Techne has reached an agreement to acquire Exosome Diagnostics, putting the firm in a stronger position in the emerging liquid biopsy and precision medicine spaces.